News

We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...
Two young elephants at the Cincinnati Zoo, Sanjay and Kabir, overcame a deadly virus thanks to a new vaccine introduced to ...
Two young male elephants, Sanjay and Kabir, who were vaccinated in 2024, later tested positive for Elephant Endotheliotropic ...